Shah Nimish P has filed 5 insider transactions across 1 company since July 2023.
Most recent transaction: a purchase of 365853 shares of Apogee Therapeutics, Inc. ($APGE) on October 10, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 10, 2025 | Apogee Therapeutics, Inc. | $APGE | Shah Nimish P | Not found | P | Pre-Funded Warrants (Right to Buy) | 365853 | $41.00 | 365,853.0000 | 46,016,542 | 9999.99% | 0.80% |
| June 17, 2025 | Apogee Therapeutics, Inc. | $APGE | Shah Nimish P | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 5, 2024 | Apogee Therapeutics, Inc. | $APGE | Shah Nimish P | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| July 13, 2023 | Apogee Therapeutics, Inc. | $APGE | Shah Nimish P | Director | P | Common Stock | 1750000 | $17.00 | 1,750,000.0000 | 0 | 9999.99% | 0.00% |
| July 13, 2023 | Apogee Therapeutics, Inc. | $APGE | Shah Nimish P | Director | A | Stock Option (Right to Buy) | 47758 | $0.00 | 47,758.0000 | 0 | 9999.99% | 0.00% |